Primerica, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Primerica, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.29B | Feb 27, 2026 |
| FY2024 | Dec 31, 2024 | $788.11M | Feb 28, 2025 |
| FY2024 | Sep 30, 2024 | $774.13M | Feb 28, 2025 |
| FY2024 | Jun 30, 2024 | $790.96M | Feb 28, 2025 |
| FY2024 | Mar 31, 2024 | $735.95M | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | $706.19M | Feb 28, 2025 |
| FY2024 | Sep 30, 2023 | $697.50M | Feb 28, 2025 |
| FY2024 | Jun 30, 2023 | $673.50M | Feb 28, 2025 |
| FY2024 | Mar 31, 2023 | $671.33M | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | $2.66B | Feb 28, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $470.52M | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | $576.60M | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | $472.07M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $477.36M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $386.16M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $93.56M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $96.22M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $97.45M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $79.17M | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $86.54M | Feb 28, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $901.18M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $862.09M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $692.52M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $757.67M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $656.96M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $643.42M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $485.51M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $478.07M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $391.54M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $294.43M | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $3.91M | Feb 28, 2012 |
| FY2011 | Dec 31, 2010 | $9.86M | Feb 28, 2012 |
| FY2011 | Dec 31, 2009 | $4.89M | Feb 28, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.01B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $14.58B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $15.03B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $14.64B | Feb 28, 2024 |
| FY2023 | Dec 31, 2021 | $16.20B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $14.91B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $13.69B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $12.60B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $12.46B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $11.44B | Feb 26, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.57B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $12.32B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $12.96B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $12.61B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $14.03B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $13.07B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $12.04B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $11.13B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $11.04B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $10.22B | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.45B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.26B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.07B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.03B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $925.43M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.84B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.65B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $1.46B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.42B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.22B | Feb 26, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $127.71M | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $127.71M | Feb 28, 2024 |
| FY2023 | Dec 31, 2021 | $179.15M | Feb 28, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.42B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.23B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.28B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.15B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.00B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.71B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.59B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.49B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.38B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $1.14B | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $756.23M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $687.82M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $594.15M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $489.24M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $392.50M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $547.57M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $256.88M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $262.14M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $279.96M | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $211.98M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $374.43M | Feb 27, 2013 |
| FY2012 | Dec 31, 2011 | $300.00M | Feb 27, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22 | Feb 27, 2026 |
| FY2024 | Dec 31, 2024 | 4 | Feb 28, 2025 |
| FY2024 | Sep 30, 2024 | 4 | Feb 28, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Mar 31, 2024 | 3 | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | 4 | Feb 28, 2025 |
| FY2024 | Sep 30, 2023 | 4 | Feb 28, 2025 |
| FY2024 | Jun 30, 2023 | 3 | Feb 28, 2025 |
| FY2024 | Mar 31, 2023 | 3 | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | 12 | Feb 28, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22 | Feb 27, 2026 |
| FY2024 | Dec 31, 2024 | 4 | Feb 28, 2025 |
| FY2024 | Sep 30, 2024 | 4 | Feb 28, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Feb 28, 2025 |
| FY2024 | Mar 31, 2024 | 3 | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | 4 | Feb 28, 2025 |
| FY2024 | Sep 30, 2023 | 4 | Feb 28, 2025 |
| FY2024 | Jun 30, 2023 | 3 | Feb 28, 2025 |
| FY2024 | Mar 31, 2023 | 3 | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | 12 | Feb 28, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31.81M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 33.37M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 35.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | 36.82M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | 39.37M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | 39.31M | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | 41.21M | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | 42.69M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | 44.25M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | 45.72M | Feb 28, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.05M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $112.81M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $93.72M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $83.78M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $74.64M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $64.35M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $57.63M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $44.14M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $35.82M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $33.37M | Feb 26, 2019 |